Write a reviewFor vendors
♡
Home / Investors / Kanad Das

Kanad Das

Venture Fund · San Francisco

About Kanad Das

Venture capital investor (Interim CBO SiteOne Therapeutics) based in San Francisco, California. Focus areas include Health Care, Drug Discovery, Wellness. Invests at series b, series a stage. Past investments include Stanford University, SPARK Program, Sentien Biotechnologies, Inc..

Investment focus

Stages
Series BSeries A
Sectors
Health CareDrug DiscoveryWellnessEngineeringBiotechnologyDrug DevelopmentResearchMedicalB2BPharmaceuticalsRisk Management

Portfolio

No portfolio companies recorded yet; Kanad Das reports 9 investments overall.

Similar investors

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Goldman

Venture Fund · New York City
Series BHealth CareTalent ManagementE-commerceWellness+16
60Investments
—Exits

Adam Goulburn

Venture Fund · New York City
Series BHealth CareRegenerative MedicineDrug DiscoveryData Science+16
60Investments
—Exits

Adam Greene

Venture Fund · New York City
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)+14
60Investments
—Exits

Adam Margolin

Venture Fund · Boston
Series BAdvertisingHealth CareWearablesE-commerce+16
60Investments
—Exits